Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9387)
All Articles published online
|
Publishing Process of This Article
|
Mar 21, 2013 (publication date) through Jul 4, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Liu C, Xiao GQ, Yan LN, Li B, Jiang L, Wen TF, Wang WT, Xu MQ, Yang JY. Value of α-fetoprotein in association with clinicopathological features of hepatocellular carcinoma. World J Gastroenterol 2013; 19(11): 1811-1819 [PMID: 23555170 DOI: 10.3748/wjg.v19.i11.1811] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i11/1811.htm |
| Number | Citing Articles |
| 1 |
Sevil Uygun Ilikhan, Muammer Bilici, Hatice Sahin, Ayşe Semra Demir Akca, Murat Can, Ibrahim Ilker Oz, Berrak Guven, M Cagatay Buyukuysal, Yucel Ustundag. Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(22): 6999-7007 doi: 10.3748/wjg.v21.i22.6999
|
| 2 |
Bo Hu, Xin-Ting Sang, Xiao-Bo Yang. Paraneoplastic leukemoid reaction in a patient with sarcomatoid hepatocellular carcinoma: A case report. World Journal of Clinical Cases 2019; 7(11): 1330-1336 doi: 10.12998/wjcc.v7.i11.1330
|
| 3 |
Lihong Shen, Lijia Shao, Shengchun Feng. Preoperative serum glutathione reductase activity and alpha-fetoprotein level are associated with early postoperative recurrence of hepatocellular carcinoma. Journal of Laboratory Medicine 2025; 49(1): 46 doi: 10.1515/labmed-2024-0035
|
| 4 |
Hung-Wen Tsai, Chung-Liang Ho, Shu-Wen Cheng, Yih-Jyh Lin, Chou-Cheng Chen, Pin-Nan Cheng, Chia-Jui Yen, Ting-Tsung Chang, Po-Min Chiang, Shih-Huang Chan, Cheng-Hsun Ho, Shu-Hui Chen, Yi-Wen Wang, Nan-Haw Chow, Jou-Chun Lin. Progesterone receptor membrane component 1 as a potential prognostic biomarker for hepatocellular carcinoma. World Journal of Gastroenterology 2018; 24(10): 1152-1166 doi: 10.3748/wjg.v24.i10.1152
|
| 5 |
Chia-Jui Yen, Masatoshi Kudo, Ho-Yeong Lim, Chih-Hung Hsu, Arndt Vogel, Giovanni Brandi, Rebecca Cheng, Ioana Simona Nitu, Paolo Abada, Yanzhi Hsu, Andrew X. Zhu, Yoon-Koo Kang. Efficacy and Safety of Ramucirumab in Asian and Non-Asian Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Individual Data Analysis of Two Randomized Studies. Liver Cancer 2020; 9(4): 440 doi: 10.1159/000506946
|
| 6 |
Ziwei Guo, Jun Liang. Lipid-Based Factors: A Promising New Biomarker for Predicting Prognosis and Conditional Survival Probability in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2022; : 869 doi: 10.2147/JHC.S360871
|
| 7 |
Guoyi Wu, Jing Wu, Xiaoben Pan, Bo Liu, Zhicheng Yao, Yuan Guo, Xiaolei Shi, Yitao Ding. Racial disparities in alpha‐fetoprotein testing and alpha‐fetoprotein status associated with the diagnosis and outcome of hepatocellular carcinoma patients. Cancer Medicine 2019; 8(15): 6614 doi: 10.1002/cam4.2549
|
| 8 |
Jeong-Ju Yoo, Goh Eun Chung, Jeong-Hoon Lee, Joon Yeul Nam, Young Chang, Jeong Min Lee, Dong Ho Lee, Hwi Young Kim, Eun Ju Cho, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon. Sub-classification of Advanced-Stage Hepatocellular Carcinoma: A Cohort Study Including 612 Patients Treated with Sorafenib. Cancer Research and Treatment 2018; 50(2): 366 doi: 10.4143/crt.2017.126
|
| 9 |
Yi-Fei Li, Qiong-Qiong Hou, Shuang Zhao, Xiaoyan Chen, Min Tang, Lin Li. Identification of tumor-specific neoantigens and immune clusters of hepatocellular carcinoma for mRNA vaccine development. Journal of Cancer Research and Clinical Oncology 2023; 149(2): 623 doi: 10.1007/s00432-022-04285-7
|
| 10 |
Ines Dhifallah, Marwa Khedhiri, Anissa Chouikha, Ghassen Kharroubi, Walid Hammami, Amel Sadraoui, Mohamed Msaddek Azzouz, Nadia Maamouri, Tahar Khalfallah, Henda Triki, Pascal Pineau, Olfa Bahri. Hepatitis viruses take advantage of traditional practices to increase the burden of hepatocellular carcinoma in Tunisia. Archives of Virology 2020; 165(1): 33 doi: 10.1007/s00705-019-04440-5
|
| 11 |
Min Du, Lingli Chen, Jing Zhao, Feng Tian, Haiying Zeng, Yunshan Tan, Huichuan Sun, Jian Zhou, Yuan Ji. Microvascular invasion (MVI) is a poorer prognostic predictor for small hepatocellular carcinoma. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-38
|
| 12 |
Hongbin Zhang, Siyuan Chai, Lintao Chen, Yubizhuo Wang, Yongna Cheng, Quan Fang, Guosen Wu, Xiangming Wang, Wenjie Liang, Wenbo Xiao. MRI Features of Hepatic Sarcomatoid Carcinoma Different From Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.611738
|
| 13 |
ZiHao Ni, BoLin Wu, Meng Li, Xue Han, XiaoWen Hao, Yue Zhang, Wen Cheng, CunLi Guo. Prediction Model and Nomogram of Early Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation Based on Logistic Regression Analysis. Ultrasound in Medicine & Biology 2022; 48(9): 1733 doi: 10.1016/j.ultrasmedbio.2022.04.217
|
| 14 |
Camille Martenon Brodeur, Philippe Thibault, Mathieu Durand, Jean-Pierre Perreault, Martin Bisaillon. Dissecting the expression landscape of cytochromes P450 in hepatocellular carcinoma: towards novel molecular biomarkers. Genes & Cancer 2019; 10(3-4): 97 doi: 10.18632/genesandcancer.190
|
| 15 |
S.S. Haque, Ravi Bhushan Raman, Mehboobus Salam. Liver Cancer - Genesis, Progression and Metastasis. 2023; doi: 10.5772/intechopen.105856
|
| 16 |
Lingzhan Meng, Hu Li, Yingjie Ji, Peng Yu, Zizheng Wang, Li Cao, Bin Shi, Yanling Shao, Jin Yan, Yinjie Gao, Zhenyu Zhu. Efficacy, safety, and biomarker analysis of TACE combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma: a real-world study. Cancer Immunology, Immunotherapy 2024; 74(1) doi: 10.1007/s00262-024-03857-5
|
| 17 |
A N L L Lalisang, W S Jeo, Y Moenadjat, T J M Lalisang. Correlation Between Serum Level of Alpha-Fetoprotein and Histological Differentiation Grade of Hepatocellular Carcinoma. Journal of Physics: Conference Series 2018; 1073: 032056 doi: 10.1088/1742-6596/1073/3/032056
|
| 18 |
Xiaojing Ren, Yuanyuan Ji, Xuhua Jiang, Xun Qi. Down-regulation of siglec-2 (CD22) predicts worse overall survival from HBV-related early-stage hepatocellular carcinoma: a preliminary analysis from Gene Expression Omnibus. Bioscience Reports 2018; 38(6) doi: 10.1042/BSR20181423
|
| 19 |
Rehan Ali, Yihe Yang, Mark Antkowiak, Ahmed Gabr, Ronald Mora, Nadine Abouchaleh, Ali Al Asadi, Laura Kulik, Daniel Ganger, Michael Abecassis, Nitin Kataraya, Mary Mulcahy, Al Benson, Devalingam Mahalingam, Bartley Thornburg, Samdeep Mouli, Robert J. Lewandowski, Riad Salem, Ahsun Riaz. Prognosticating Survival in Hepatocellular Carcinoma with Elevated Baseline Alpha-fetoprotein Treated with Radioembolization Using a Novel Laboratory Scoring System: Initial Development and Validation. CardioVascular and Interventional Radiology 2019; 42(5): 700 doi: 10.1007/s00270-019-02191-z
|
| 20 |
V. B. Weeda, D. C. Aronson, J. Verheij, W. H. Lamers. Is hepatocellular carcinoma the same disease in children and adults? Comparison of histology, molecular background, and treatment in pediatric and adult patients. Pediatric Blood & Cancer 2019; 66(2) doi: 10.1002/pbc.27475
|
| 21 |
Yukai He, Yuan Hong, Gerald J Mizejewski. Engineering α-fetoprotein-based Gene Vaccines to Prevent and Treat Hepatocellular Carcinoma: Review and Future Prospects. Immunotherapy 2014; 6(6): 725 doi: 10.2217/imt.14.46
|
| 22 |
ZiHao Ni, BoLin Wu, Zhao Liu, QiuCheng Wang, Xue Han, Wen Cheng, CunLi Guo. Clinical value of combined preoperative–postoperative neutrophil-to-lymphocyte ratio in predicting hepatocellular carcinoma prognosis after radiofrequency ablation. The British Journal of Radiology 2023; 96(1145) doi: 10.1259/bjr.20220887
|
| 23 |
Richa Surit, Ravi Shekhar, Dinesh Kumar Sinha, Sanjeet Kumar Singh, Uday Kumar, Nidhi Prasad. Hepatitis B in hepatocellular carcinoma patients and its correlation with alpha-fetoprotein and liver enzymes. Journal of Cancer Research and Therapeutics 2022; 18(4): 903 doi: 10.4103/jcrt.JCRT_239_19
|
| 24 |
Di Zhang, Qi Wei, Ge-Ge Wu, Xian-Ya Zhang, Wen-Wu Lu, Wen-Zhi Lv, Jin-Tang Liao, Xin-Wu Cui, Xue-Jun Ni, Christoph F. Dietrich. Preoperative Prediction of Microvascular Invasion in Patients With Hepatocellular Carcinoma Based on Radiomics Nomogram Using Contrast-Enhanced Ultrasound. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.709339
|
| 25 |
Samir F. Zohny, Ahlam H. Mahmoud, Ibrahim H. Borai, Faten S. Bayoumi, Eman Eissa. Chemopreventive and therapeutic efficacy of Salsola inermis extract against N-nitrosodiethylamine-initiated and phenobarbital-promoted hepatocellular carcinogenesis in Wistar rats. Biomedicine & Aging Pathology 2013; 3(4): 229 doi: 10.1016/j.biomag.2013.08.002
|
| 26 |
Hiroji Shinkawa, Shogo Tanaka, Shigekazu Takemura, Ryosuke Amano, Kenjiro Kimura, Masahiko Kinoshita, Kanae Takahashi, Shuichiro Matsuzaki, Shoji Kubo. Nomograms predicting extra- and early intrahepatic recurrence after hepatic resection of hepatocellular carcinoma. Surgery 2021; 169(4): 922 doi: 10.1016/j.surg.2020.10.012
|
| 27 |
Ashokachakkaravarthy Kandasamy, Biju Pottakkat. Alpha-fetoprotein: A molecular bootstrap for hepatocellular carcinoma. International Journal of Molecular and Immuno Oncology 2020; 5: 92 doi: 10.25259/IJMIO_5_2020
|
| 28 |
Sih‐Han Liao, Tung‐Hung Su, Yung‐Ming Jeng, Po‐Chin Liang, Ding‐Shinn Chen, Chien‐Hung Chen, Jia‐Horng Kao. Clinical Manifestations and Outcomes of Patients with Sarcomatoid Hepatocellular Carcinoma. Hepatology 2019; 69(1): 209 doi: 10.1002/hep.30162
|
| 29 |
Andrea Notarpaolo, Richard Layese, Paolo Magistri, Maria Gambato, Michele Colledan, Giulia Magini, Lucia Miglioresi, Alessandro Vitale, Giovanni Vennarecci, Cecilia D Ambrosio, Patrizia Burra, Fabrizio Di Benedetto, Stefano Fagiuoli, Marco Colasanti, Giuseppe Maria Ettorre, Arnoldo Andreoli, Umberto Cillo, Alexis Laurent, Sandrine Katsahian, Etienne Audureau, Françoise Roudot-Thoraval, Christophe Duvoux. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC. Journal of Hepatology 2017; 66(3): 552 doi: 10.1016/j.jhep.2016.10.038
|
| 30 |
Lele Miao, Zhengchao Zhang, Zhijian Ren, Yumin Li. Application of Immunotherapy in Hepatocellular Carcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.699060
|
| 31 |
Mohammed El Fayoumie, Mahmoud Abdelhady, Ahmed Gawish, Usama Hantour, Ismail Abdelkhaleek, Mohamed Abdelraheem, Alaa Alsawak, Ahmed Alwassief, Ashraf Elbahrawy. Changing Patterns of Hepatocellular Carcinoma after Treatment with Direct Antiviral Agents. Gastrointestinal Tumors 2020; 7(1-2): 50 doi: 10.1159/000505326
|
| 32 |
HUAN-YU WANG, LIANG ZHANG, JIAN WU, ZI-JIAN ZHANG, BAO-GANG PENG, LI-JIAN LIANG, QI ZHOU. Adult hepatic cavernous hemangioma with highly elevated α-fetoprotein: A case report and review of the literature. Oncology Letters 2015; 9(2): 637 doi: 10.3892/ol.2014.2769
|
| 33 |
Shumin Li, Qianwen Zeng, Ruiming Liang, Jianyan Long, Yihao Liu, Han Xiao, Kaiyu Sun. Using Systemic Inflammatory Markers to Predict Microvascular Invasion Before Surgery in Patients With Hepatocellular Carcinoma. Frontiers in Surgery 2022; 9 doi: 10.3389/fsurg.2022.833779
|
| 34 |
Ahsun Riaz, Riad Salem. Laboratory and Imaging Prognostic Indicators following Arterial Locoregional Therapies for Hepatocellular Carcinoma Survival. Journal of Vascular and Interventional Radiology 2019; 30(12): 1893 doi: 10.1016/j.jvir.2019.09.003
|
| 35 |
Cheon-Soo Park, Yong-Kyu Chung, Sung-Hwa Kang, Shin Hwang. Diagnostic predictability of hepatocellular carcinoma tumor markers in patients waiting for living donor liver transplantation. Annals of Liver Transplantation 2022; 2(1): 34 doi: 10.52604/alt.22.0012
|
| 36 |
Natalia Salinas Parra, Heather M. Ross, Adnan Khan, Marisa Wu, Risa Goldberg, Lokesh Shah, Sarah Mukhtar, Jacob Beiriger, Alexis Gerber, Dina Halegoua-DeMarzio. Advancements in the Diagnosis of Hepatocellular Carcinoma. International Journal of Translational Medicine 2023; 3(1): 51 doi: 10.3390/ijtm3010005
|
| 37 |
Yuan Hong, Yibing Peng, Sheng Z. Guo, Jose Guevara-Patino, Junfeng Pang, Lisa H. Butterfield, Nahid F. Mivechi, David H. Munn, David L. Bartlett, Yukai He. Epitope-optimized alpha-fetoprotein genetic vaccines prevent carcinogen-induced murine autochthonous hepatocellular carcinoma. Hepatology 2014; 59(4): 1448 doi: 10.1002/hep.26893
|
| 38 |
Carla S. Coffin, Scott K. Fung, Fernando Alvarez, Curtis L. Cooper, Karen E. Doucette, Claire Fournier, Erin Kelly, Hin Hin Ko, Mang M Ma, Steven R Martin, Carla Osiowy, Alnoor Ramji, Edward Tam, Jean Pierre Villeneuve. Management of Hepatitis B Virus Infection: 2018 Guidelines from the Canadian Association for the Study of Liver Disease and Association of Medical Microbiology and Infectious Disease Canada. Canadian Liver Journal 2018; 1(4): 156 doi: 10.3138/canlivj.2018-0008
|
| 39 |
Nurbubu T. Moldogazieva, Daria S. Ostroverkhova, Nikolai N. Kuzmich, Vladimir V. Kadochnikov, Alexander A. Terentiev, Yuri B. Porozov. Elucidating Binding Sites and Affinities of ERα Agonists and Antagonists to Human Alpha-Fetoprotein by In Silico Modeling and Point Mutagenesis. International Journal of Molecular Sciences 2020; 21(3): 893 doi: 10.3390/ijms21030893
|
| 40 |
Rui Gao, Chunli Cai, Jiancheng Gan, Xi Yang, Zeyu Shuang, Min Liu, Shengping Li, Hua Tang. miR-1236 down-regulates alpha-fetoprotein, thus causing PTEN accumulation, which inhibits the PI3K/Akt pathway and malignant phenotype in hepatoma cells. Oncotarget 2015; 6(8): 6014 doi: 10.18632/oncotarget.3338
|
| 41 |
Jing‐Houng Wang, Kwong‐Ming Kee, Chih‐Yun Lin, Chao‐Hung Hung, Chien‐Hung Chen, Chuan‐Mo Lee, Sheng‐Nan Lu. Validation and modification of a proposed substaging system for patients with intermediate hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2015; 30(2): 358 doi: 10.1111/jgh.12686
|
| 42 |
Haruki Kimura, Kazuyoshi Ohkawa, Masanori Miyazaki, Mitsuru Sakakibara, Kazuho Imanaka, Takeshi Tamura, Hironari Sueyoshi, Ryoji Takada, Nobuyasu Fukutake, Hiroyuki Uehara, Reiko Ashida, Tatsuya Ioka, Tetsuro Nakazawa, Katsuyuki Nakanishi, Kazuhiro Katayama. Subclassification of patients with intermediate-stage (Barcelona Clinic Liver Cancer stage-B) hepatocellular carcinoma using the up-to-seven criteria and serum tumor markers. Hepatology International 2017; 11(1): 105 doi: 10.1007/s12072-016-9771-0
|
| 43 |
Narongsak Rungsakulkij, Wikran Suragul, Somkit Mingphruedhi, Pongsatorn Tangtawee, Paramin Muangkaew, Suraida Aeesoa. Prognostic role of alpha-fetoprotein response after hepatocellular carcinoma resection. World Journal of Clinical Cases 2018; 6(6): 110-120 doi: 10.12998/wjcc.v6.i6.110
|
| 44 |
Gui-Min Hou, Hai-ling Liu, Hong Wu, Yong Zeng. Prediction of Prognosis for cHCC-CC Patients After Surgery: Comparison of Tumor Marker Score Based on AFP, CEA, CA19-9, and Other Clinical Stages. Annals of Surgical Oncology 2021; 28(12): 7647 doi: 10.1245/s10434-021-09949-1
|
| 45 |
Ting Sun, Ruicen Li, Yiwen Qiu, Shu Shen, Wentao Wang. New Thresholds for AFP and Des-γ-Carboxy Prothrombin in Chronic Liver Disease Depending on the Use of Nucleoside Analogs and an Integrated Nomogram. International Journal of General Medicine 2021; : 6149 doi: 10.2147/IJGM.S335400
|
| 46 |
Tianying Ren, Xu Hou, Xin Zhang, Dongliang Chen, Juan Li, Yingnan Zhu, Zhiheng Liu, Dawei Yang. Validation of combined AFP, AFP-L3, and PIVKA II for diagnosis and monitoring of hepatocellular carcinoma in Chinese patients. Heliyon 2023; 9(11): e21906 doi: 10.1016/j.heliyon.2023.e21906
|
| 47 |
Mingjie Yao, Jingmin Zhao, Fengmin Lu. Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma. Oncotarget 2016; 7(4): 3702 doi: 10.18632/oncotarget.6913
|
| 48 |
Tomohiko Sakabe, Junya Azumi, Yoshihisa Umekita, Kan Toriguchi, Etsuro Hatano, Yasuaki Hirooka, Goshi Shiota. Prognostic relevance of miR‐137 in patients with hepatocellular carcinoma. Liver International 2017; 37(2): 271 doi: 10.1111/liv.13213
|
| 49 |
Shashi Bala Paul, Pabitra Sahu, Vishnubhatla Sreenivas, Neeti Nadda, Shivanand R. Gamanagatti, Baibaswata Nayak, S. Shalimar, Subrat K. Acharya. Prognostic role of serial alpha-fetoprotein levels in hepatocellular carcinoma treated with locoregional therapy. Scandinavian Journal of Gastroenterology 2019; 54(9): 1132 doi: 10.1080/00365521.2019.1660403
|
| 50 |
Yoh Zen, David Britton, Vikram Mitra, Andrew Brand, Stephan Jung, Christopher Loessner, Malcolm Ward, Ian Pike, Nigel Heaton, Alberto Quaglia. Protein expression profiles of chemo-resistant mixed phenotype liver tumors using laser microdissection and LC–MS/MS proteomics. EuPA Open Proteomics 2013; 1: 38 doi: 10.1016/j.euprot.2013.10.001
|
| 51 |
Chyntia Olivia Maurine Jasirwan, Alessa Fahira, Lianda Siregar, Imelda Loho. The alpha-fetoprotein serum is still reliable as a biomarker for the surveillance of hepatocellular carcinoma in Indonesia. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01365-1
|
| 52 |
Mohamed Bouattour, Audrey Payancé, Johanna Wassermann. Evaluation of antiangiogenic efficacy in advanced hepatocellular carcinoma: Biomarkers and functional imaging. World Journal of Hepatology 2015; 7(20): 2245-2263 doi: 10.4254/wjh.v7.i20.2245
|
| 53 |
Maria J Citores, Jose L Lucena, Sara de la Fuente, Valentin Cuervas-Mons. Serum biomarkers and risk of hepatocellular carcinoma recurrence after liver transplantation. World Journal of Hepatology 2019; 11(1): 50-64 doi: 10.4254/wjh.v11.i1.50
|
| 54 |
Sunyoung Lee, Tae Wook Kang, Kyoung Doo Song, Min Woo Lee, Hyunchul Rhim, Hyo Keun Lim, So Yeon Kim, Dong Hyun Sinn, Jong Man Kim, Kyunga Kim, Sang Yun Ha. Effect of Microvascular Invasion Risk on Early Recurrence of Hepatocellular Carcinoma After Surgery and Radiofrequency Ablation. Annals of Surgery 2021; 273(3): 564 doi: 10.1097/SLA.0000000000003268
|
| 55 |
Zhengwei Zha, Wenyue Wu, Qianqian Zhang, Xi Wang, Xuecan Mei, Yi Xiang, Derun Kong. Screening, clinical features and prognostic analysis of liver cirrhosis-related hepatocellular carcinoma. Scandinavian Journal of Gastroenterology 2021; 56(8): 948 doi: 10.1080/00365521.2021.1938208
|
| 56 |
Yeonjung Ha, Ju Hyun Shim, Seon‐Ok Kim, Kang Mo Kim, Young‐Suk Lim, Han Chu Lee. Clinical appraisal of the recently proposed Barcelona Clinic Liver Cancer stage B subclassification by survival analysis. Journal of Gastroenterology and Hepatology 2014; 29(4): 787 doi: 10.1111/jgh.12452
|
| 57 |
Zhan-Cheng Qiu, You-Wei Wu, Jun-Long Dai, Wei-Li Qi, Chu-Wen Chen, Yue-Qing Xu, Jun-Yi Shen, Chuan Li, Tian-Fu Wen. Tumor burden score combined with AFP and PIVKA-II (TAP score) to predict the prognosis of hepatocellular carcinoma patients after radical liver resection. Langenbeck's Archives of Surgery 2025; 410(1) doi: 10.1007/s00423-025-03650-7
|
| 58 |
Kazunari Sasaki, Masamichi Matsuda, Yu Ohkura, Yusuke Kawamura, Masafumi Inoue, Masaji Hashimoto, Kenji Ikeda, Hiromitsu Kumada, Goro Watanabe. Implication of an extremely high preoperative alpha-fetoprotein value (>4,000 ng/mL) for the long-term outcomes of hepatectomy for resectable hepatocellular carcinoma. Surgery 2015; 157(2): 223 doi: 10.1016/j.surg.2014.09.010
|
| 59 |
Guanghua Liu, Fang Xia, Guoping Fan, Juming Yu, Lei Bao, Caiyuan Zhang, Runmin Chi, Tingting Zhang, Lijun Wang, Feng Shen, Dengbin Wang. Type 2 diabetes mellitus worsens the prognosis of intermediate-stage hepatocellular carcinoma after transarterial chemoembolization. Diabetes Research and Clinical Practice 2020; 169: 108375 doi: 10.1016/j.diabres.2020.108375
|
| 60 |
Ting Wang, Kun-He Zhang. New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01316
|
| 61 |
Min Luo, Fan Yang, Sheng-xin Huang, Zhi-peng Kuang, Xiao-ling Luo, Yuan-dong Li, Ji-ning Wu, Yu-an Xie. Two-Stage Model of Chemically Induced Hepatocellular Carcinoma in Mouse. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2012; 20(11): 517 doi: 10.3727/096504013X13747716581336
|
| 62 |
Marco Biolato, Giuseppe Marrone, Luca Miele, Antonio Gasbarrini, Antonio Grieco. Liver transplantation for intermediate hepatocellular carcinoma: An adaptive approach. World Journal of Gastroenterology 2017; 23(18): 3195-3204 doi: 10.3748/wjg.v23.i18.3195
|
| 63 |
Eun‐Ran Park, Sang‐Bum Kim, Jee‐San Lee, Yang‐Hyun Kim, Dong‐Hyoung Lee, Eung‐Ho Cho, Sun‐Hoo Park, Chul Ju Han, Bu‐Yeo Kim, Dong Wook Choi, Young Do Yoo, Ami Yu, Jae Won Lee, Ja June Jang, Young Nyun Park, Kyung‐Suk Suh, Kee‐Ho Lee. The mitochondrial hinge protein, UQCRH, is a novel prognostic factor for hepatocellular carcinoma. Cancer Medicine 2017; 6(4): 749 doi: 10.1002/cam4.1042
|
| 64 |
Sylene C.R. Carvalho, Luydson R.S. Vasconcelos, Leonardo da Fonseca, Rodrigo F. Carmo, Michele T. Tomitão, Dayse C.B.L. Aroucha, Leila M.M.B. Pereira, José Tadeu Stefano, Ulysses Ribeiro-Júnior, Claudia P. Oliveira, Flair J. Carrilho. Methylene tetrahydrofolate reductase (MTHFR) and vascular endothelial growth factor (VEGF) polymorphisms in Brazilian patients with Hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC). Clinics 2021; 76: e2881 doi: 10.6061/clinics/2021/e2881
|
| 65 |
So Hyun Park, Bohyun Kim, Sehee Kim, Suyoung Park, Yeon Ho Park, Seung Kak Shin, Pil Soo Sung, Joon-Il Choi. Estimating postsurgical outcomes of patients with a single hepatocellular carcinoma using gadoxetic acid–enhanced MRI: risk scoring system development and validation. European Radiology 2023; 33(5): 3566 doi: 10.1007/s00330-023-09539-7
|
| 66 |
Zhao-Dan Ye, Li Zhuang, Meng-Chen Song, Zhe Yang, Wu Zhang, Jing-Feng Zhang, Guo-Hong Cao. Drug-eluting bead transarterial chemoembolization as neoadjuvant therapy pre-liver transplantation for advanced-stage hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2024; 16(6): 2476-2486 doi: 10.4251/wjgo.v16.i6.2476
|
| 67 |
Yang-Xun Pan, Xu-Qi Sun, Zi-Li Hu, Wa Xie, Ke-Xin Nie, Ai-Ping Fang, Ying-Yao Zhang, Yi-Zhen Fu, Jin-Bin Chen, Jun-Cheng Wang, Xin Wang, Yao-Jun Zhang, Dan-Dan Hu, Min-Shan Chen. Prognostic Values of Alpha-Fetoprotein and Des-Gamma-Carboxyprothrombin in Hepatocellular Carcinoma in China: An Analysis of 4792 Patients. Journal of Hepatocellular Carcinoma 2021; : 657 doi: 10.2147/JHC.S316223
|
| 68 |
Merve Karayazili, Ulgen Celtik, Eda Ataseven, Deniz Nart, Orkan Ergun. Evaluation of surgical strategies and long-term outcomes in pediatric hepatocellular carcinoma. Pediatric Surgery International 2024; 40(1) doi: 10.1007/s00383-024-05721-0
|
| 69 |
WEY-RAN LIN, CHAO-WEI HSU, YI-CHENG CHEN, MING-LING CHANG, KUNG-HAO LIANG, YA-HUI HUANG, CHAU-TING YEH. GALNT14 genotype, α-fetoprotein and therapeutic side effects predict post-chemotherapy survival in patients with advanced hepatocellular carcinoma. Molecular and Clinical Oncology 2014; 2(4): 630 doi: 10.3892/mco.2014.294
|
| 70 |
Darren W. Chua, Ye-Xin Koh, John C. Allen, Chung-Yip Chan, Ser-Yee Lee, Peng-Chung Cheow, Premaraj Jeyaraj, Jin-Yao Teo, Pierce K. Chow, Alexander Y. Chung, London L. Ooi, Brian K.P. Goh. Impact of spontaneous rupture on the survival outcomes after liver resection for hepatocellular carcinoma: A propensity matched analysis comparing ruptured versus non-ruptured tumors. European Journal of Surgical Oncology 2019; 45(9): 1652 doi: 10.1016/j.ejso.2019.03.044
|
| 71 |
Christopher Welberry, Isabel Macdonald, Jane McElveen, Celine Parsy-Kowalska, Jared Allen, Graham Healey, William Irving, Andrea Murray, Caroline Chapman, Vasilis Kosmoliaptsis. Tumor-associated autoantibodies in combination with alpha-fetoprotein for detection of early stage hepatocellular carcinoma. PLOS ONE 2020; 15(5): e0232247 doi: 10.1371/journal.pone.0232247
|
| 72 |
Juncheng Wang, Yize Mao, Yongcheng Liu, Zhenxin Chen, Minshan Chen, Xiangming Lao, Shengping Li. Hepatocellular Carcinoma in Children and Adolescents: Clinical Characteristics and Treatment. Journal of Gastrointestinal Surgery 2017; 21(7): 1128 doi: 10.1007/s11605-017-3420-3
|
| 73 |
Lili Wang, Yanyan Zhang, Junfeng Li, Shunlin Guo, Jialiang Ren, Zhihao Li, Xin Zhuang, Jingmei Xue, Junqiang Lei. A Nomogram of Magnetic Resonance Imaging for Preoperative Assessment of Microvascular Invasion and Prognosis of Hepatocellular Carcinoma. Digestive Diseases and Sciences 2023; 68(12): 4521 doi: 10.1007/s10620-023-08022-z
|
| 74 |
Hana Hadi, Wan Muhammad Azfar Wan Shuaib, Raja Affendi Raja Ali, Hanita Othman. Utility of PIVKA-II and AFP in Differentiating Hepatocellular Carcinoma from Non-Malignant High-Risk Patients. Medicina 2022; 58(8): 1015 doi: 10.3390/medicina58081015
|
| 75 |
Renxiang Xia, Jing Peng, Jian He, Ping Jiang, Chunyan Yuan, Xiaoli Liu, Yunqing Yao. The Serious Challenge of Occult Hepatitis B Virus Infection-Related Hepatocellular Carcinoma in China. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.840825
|
| 76 |
Amina Settar, Hassina Khaldoun, Dalila Tarzaali, Nacima Djennane, Chahrazed Makhlouf, Ichrak Selmani, Oularbi Yasmine, Khaldoune Amel. Lambda cyhalothrin and chlorantraniliprole caused biochemical, histological, and immunohistochemical alterations in male rabbit liver: Ameliorative effect of vitamins A, D, E, C mixture. Toxicology 2023; 487: 153464 doi: 10.1016/j.tox.2023.153464
|
| 77 |
Haiqing Wang, Lunan Yan. Operative Techniques in Liver Resection. 2016; : 95 doi: 10.1007/978-94-017-7411-6_11
|
| 78 |
Bérénice Charrière, Charlotte Maulat, Bertrand Suc, Fabrice Muscari. Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma. World Journal of Hepatology 2016; 8(21): 881-890 doi: 10.4254/wjh.v8.i21.881
|
| 79 |
Justin Y. Tang, Nitin Ohri, Rafi Kabarriti, Santiago Aparo, Jennifer Chuy, Sanjay Goel, Jonathan M. Schwartz, Milan Kinkhabwala, Andreas Kaubisch, Chandan Guha. Model for End-Stage Liver Disease and Sodium Velocity Predicts Overall Survival in Nonmetastatic Hepatocellular Carcinoma Patients. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/5681979
|
| 80 |
Tsuyoshi Shimamura, Ryoichi Goto, Masaaki Watanabe, Norio Kawamura, Yasutsugu Takada. Liver Transplantation for Hepatocellular Carcinoma: How Should We Improve the Thresholds?. Cancers 2022; 14(2): 419 doi: 10.3390/cancers14020419
|
| 81 |
Zachary J. Brown, Bernd Heinrich, Tim F. Greten. Mouse models of hepatocellular carcinoma: an overview and highlights for immunotherapy research. Nature Reviews Gastroenterology & Hepatology 2018; 15(9): 536 doi: 10.1038/s41575-018-0033-6
|
| 82 |
Xu Liu, Jing Meng, Hongqin Xu, Junqi Niu. Alpha-fetoprotein to transaminase ratio is related to higher diagnostic efficacy for hepatocellular carcinoma. Medicine 2019; 98(17): e15414 doi: 10.1097/MD.0000000000015414
|
| 83 |
Xiaonan Mao, Yan Guo, Zaiming Lu, Feng Wen, Hongyuan Liang, Wei Sun. Enhanced CT Textures Derived From Computer Mathematic Distribution Analysis Enables Arterial Enhancement Fraction Being an Imaging Biomarker Option of Hepatocellular Carcinoma. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01337
|
| 84 |
Jun-yi Shen, Chuan Li, Tian-fu Wen, Lv-nan Yan, Bo Li, Wen-tao Wang, Jia-yin Yang, Ming-qing Xu. Alpha fetoprotein changes predict hepatocellular carcinoma survival beyond the Milan criteria after hepatectomy. Journal of Surgical Research 2017; 209: 102 doi: 10.1016/j.jss.2016.10.005
|
| 85 |
Youwei Wu, Wei Peng, Junyi Shen, Xiaoyun Zhang, Chuan Li, Tianfu Wen. The impact of tumor burden at the initial hepatectomy on the recurrence-to-death survival after repeat surgical resection/radiofrequency ablation: a retrospective study. BMC Surgery 2022; 22(1) doi: 10.1186/s12893-022-01643-7
|
| 86 |
Rawaa AlChalabi, Mustafa S. AL-Salmani, Semaa A. Shaban, Ahmed AbdulJabbar Suleiman. Role of Dysregulated Immune Biomarkers in Hepatocellular Carcinoma Metastasis: A Systematic Meta-Analysis Review. South Asian Journal of Cancer 2024; doi: 10.1055/s-0044-1789589
|
| 87 |
CHENG-ZUO XIAO, WEI WEI, ZHI-XING GUO, SHU-HONG LI, YONG-FA ZHANG, JIA-HONG WANG, MING SHI, RONG-PING GUO. A prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resection. Oncology Letters 2015; 10(5): 2787 doi: 10.3892/ol.2015.3677
|
| 88 |
Gouling Zhan, Honghua Peng, Lehong Zhou, Long Jin, Xueyi Xie, Yu He, Xuan Wang, Zhangyan Du, Peiguo Cao. A web-based nomogram model for predicting the overall survival of hepatocellular carcinoma patients with external beam radiation therapy: A population study based on SEER database and a Chinese cohort. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1070396
|
| 89 |
Xinjun Lu, Shanshan Deng, Jiejie Xu, Benjamin L. Green, Honghua Zhang, Guofei Cui, Yi Zhou, Yi Zhang, Hongwei Xu, Fapeng Zhang, Rui Mao, Sheng Zhong, Thorsten Cramer, Matthias Evert, Diego F. Calvisi, Yukai He, Chao Liu, Xin Chen. Combination of AFP vaccine and immune checkpoint inhibitors slows hepatocellular carcinoma progression in preclinical models. Journal of Clinical Investigation 2023; 133(11) doi: 10.1172/JCI163291
|
| 90 |
Dae Geon Ahn, Hyung Joon Kim, Hyun Kang, Hyun Woong Lee, Si Hyun Bae, Joon Hyoek Lee, Yong Han Paik, June Sung Lee. Feasibility of α-fetoprotein as a diagnostic tool for hepatocellular carcinoma in Korea. The Korean Journal of Internal Medicine 2015; 31(1): 46 doi: 10.3904/kjim.2016.31.1.46
|
| 91 |
Feng Ye, Di Ma, Xiao-Yong Gong, Yu-Chen Yang, Yong-Jun Chen. Development and validation of risk score for predicting spontaneous rupture of hepatocellular carcinoma. Annals of Surgical Treatment and Research 2020; 99(5): 268 doi: 10.4174/astr.2020.99.5.268
|
| 92 |
Xiaohong Ma, Jingwei Wei, Dongsheng Gu, Yongjian Zhu, Bing Feng, Meng Liang, Shuang Wang, Xinming Zhao, Jie Tian. Preoperative radiomics nomogram for microvascular invasion prediction in hepatocellular carcinoma using contrast-enhanced CT. European Radiology 2019; 29(7): 3595 doi: 10.1007/s00330-018-5985-y
|
| 93 |
Dong Ik Cha, Tae Wook Kang, Woo Kyoung Jeong, Jong Man Kim, Gyu-Seong Choi, Jae-Won Joh, Nam-Joon Yi, Soo Hyun Ahn. Preoperative assessment of microvascular invasion risk using gadoxetate-enhanced MRI for predicting outcomes after liver transplantation for single hepatocellular carcinoma within the Milan criteria. European Radiology 2023; 34(1): 498 doi: 10.1007/s00330-023-09936-y
|
| 94 |
Chloé Sauzay, Alexandra Petit, Anne-Marie Bourgeois, Jean-Claude Barbare, Bruno Chauffert, Antoine Galmiche, Aline Houessinon. Alpha-foetoprotein (AFP): A multi-purpose marker in hepatocellular carcinoma. Clinica Chimica Acta 2016; 463: 39 doi: 10.1016/j.cca.2016.10.006
|
| 95 |
Nokjung Kim, Myung-Won You. Hepatocellular carcinoma and macrovascular tumor thrombosis: treatment outcomes and prognostic factors for survival. Japanese Journal of Radiology 2019; 37(11): 781 doi: 10.1007/s11604-019-00868-6
|